Evidence map›Paper›PMID 42615036›Full record

ArticleDigital biomarkers

Smartwatch-Based Screening to Identify Candidates for Deep Brain Stimulation in Parkinson's Disease.

Rabie Fadil, Benjamin L Walter, Greg Kuhlman, Syed A Zaidi, Dustin A Heldman

Abstract read
In one paragraph

Article in Digital biomarkers. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rabie FadilGreat Lakes NeuroTechnologies Inc, Cleveland, OH, USA.
Benjamin L WalterCenter for Neuro-Restoration, Cleveland Clinic, Cleveland, OH, USA.
Greg KuhlmanDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati, College of Medicine, Cincinnati, OH, USA.
Syed A ZaidiDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati, College of Medicine, Cincinnati, OH, USA.
Dustin A HeldmanGreat Lakes NeuroTechnologies Inc, Cleveland, OH, USA.

Funding

DiSCERN: Advanced PD Therapy Candidacy and Evaluation SystemR44MD013767 · NIMHD · GREAT LAKES NEUROTECHNOLOGIES · PI Dustin A. Heldman · 2018 to 2026
$2.7M
NIMHD NIH HHS R44 MD013767
6 · The paper itself

Abstract

Introduction: Identifying deep brain stimulation (DBS) candidates, particularly those without access to an advanced specialty center, presents ongoing challenges. This study evaluates the feasibility of a smartwatch system for identifying DBS candidates in Parkinson's disease (PD). Methods: We recruited adults diagnosed with PD and motor complications. Participants wore a consumer smartwatch for at least 4 days per month for 8 months. The smartwatch continuously recorded motion data from its internal motion sensors. Previously validated algorithms used motion data to measure tremor, slowness, and dyskinesia. We compared various metrics in participants who were and were not recommended for DBS and developed an artificial intelligence (AI) model to predict DBS candidacy using features extracted from the motion data. Results: Twenty-three participants were included in the data analysis. Sixteen participants were considered DBS candidates; among them, ten initiated DBS during the study, and six did not due to age or personal preference. Seven participants were not DBS candidates. Bad time (presence of tremor, slowness, and/or dyskinesia as measured by the smartwatch) occurred more often in DBS candidates (3.46 ± 2.23 vs. 1.24 ± 1.23 h/day; Conclusions: The results suggest that sensors in commercial smartwatches and AI can help identify DBS candidates and detect improvements resulting from the therapy. This type of remote patient monitoring could expand access to patients who might not otherwise have considered DBS.

Indexed as

Advanced therapiesDeep brain stimulationParkinson’s diseaseRecurrent neural networksWearable sensors

Identifiers

PMID42615036
PMCPMC13485297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.